Insuficiență cardiacă cronică
Stem cell therapies hold promise for regenerating damaged myocardium in myocardial infarction and cardiomyopathy. Preclinical studies have demonstrated the potential of various stem cell types to improve cardiac function, reduce scar formation, and promote angiogenesis. Cu toate acestea, clinical translation of these findings has faced challenges, including the need for optimized cell delivery methods and the development of standardized protocols to ensure safety and efficacy.
0 Comentarii